诺诚健华 (688428)

InnoCare Pharma Limited

KSH

Tags

Innovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareContains H-SharesFund Reduction PositionsBiological ProductsTechnology Growth LayerMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 176464.40
  • Circulating A-Shares(W): 26835.97
  • Earnings Per Share(RMB): -0.0200
  • Net Assets Per Share(RMB): 3.8031
  • Operating Revenue(W RMB): 73143.42
  • Total Profit(W RMB): -3058.36
  • **Net Profit Attributable to Parent(W RMB) **: -3009.14
  • Net Profit Growth Rate(%): 88.51
  • Weighted Return on Equity(%): -0.4500
  • Operating Cash Flow Per Share(RMB): -0.0350
  • Undistributed Profit Per Share(RMB): -3.1490
  • Capital Reserve Per Share(RMB): 6.8901

2. Main Business

The main business covers:

  • R&D, production and commercialization of innovative drugs

3. Company Basic Information

  • Company Name: Innocare Pharma Limited
  • Listing Date: 2022-09-21
  • Industry: Pharmaceutical Manufacturing
  • Address: Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing
  • Website: https://www.Innocarepharma.com
  • Company Profile: On November 3, 2015, the Cayman Islands Company Registry issued a "Certificate of Incorporation" to the company, which was registered and established in the Cayman Islands under the "Cayman Islands Companies Law". At the time of its establishment, the company had an authorized share capital of USD 50,000, a total authorized number of shares of 500,000,000, with an initial par value of USD 0.0001 per share.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Fullgoal Precision Medicine Flexible Allocation Hybrid Securities Investment Fund - Class A Fund 1215.49 4.53
2 Ping An Healthcare Hybrid Securities Investment Fund - Class A Fund 862.66 3.21
3 Wanjia Economic New Momentum Hybrid Securities Investment Fund - Class A Fund 600.00 2.24
4 China Universal Healthcare Service Flexible Allocation Hybrid Securities Investment Fund - Class A Fund 545.10 2.03
5 DONG Fang Hong Healthcare Upgrade Equity Initiated Securities Investment Fund - Class A Fund 458.94 1.71
6 Bosera Healthcare Health Shanghai-Hong Kong-Shenzhen Equity Securities Investment Fund - Class A Fund 405.54 1.51
7 China Universal Daxin Flexible Allocation Hybrid Securities Investment Fund - Class A Fund 398.15 1.48
8 Fullgoal Healthcare Industry Hybrid Securities Investment Fund - Class A Fund 237.89 0.89
9 CSC Financial Healthcare Reform Flexible Allocation Hybrid Securities Investment Fund - Class A Fund 225.00 0.84
10 Ping An Pharmaceutical Selection Equity Securities Investment Fund - Class A Fund 190.17 0.71

5. Concept Sectors

  • H-Share
  • Innovative Drug
  • Margin Trading & Securities Lending
  • Consecutive Losses
  • Fund Reduction
  • STAR Market Growth Layer

Remarks

  • Data update date: 2025-11-05
  • Data source: Public Market Information